课题基金 / 基金详情

Identification of Novel Disease Drivers, Therapeutic Targets, and Biomarkers of Sepsis

Identification of Novel Disease Drivers, Therapeutic Targets, and Biomarkers of Sepsis
脓毒症新疾病驱动因素、治疗靶点和生物标志物的鉴定
批准号:
484160
负责人:
Lu Kun Ping
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
已结题
起止时间:
2023-03-01 至 2024-03-01

项目摘要

项目成果

Lu Kun Ping的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Sepsis refers to the body's exaggerated response to infection. Fifty million people develop sepsis annually, leading to one-fifth of all global deaths. Sepsis results in a life-threatening and abrupt release of small inflammatory molecules called cytokine
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Optimized Reversible Pin1 Inhibitors to Block Multiple Cancer-Driving Pathways and to Disrupt Immunosuppressive Tumor Microenvironment
  • 批准号:
    494870
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2023
  • 负责人:
    Lu Kun Ping
  • 依托单位:
Identification of Novel Disease Drivers, Therapeutic Targets, and Biomarkers of Sepsis
  • 批准号:
    494277
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2023
  • 负责人:
    Lu Kun Ping
  • 依托单位:
海外基金